en · de · es · pt
glossary-desk.peptides6908.com › Data › Chemical Background And Receptor Activity — Field Notes

Chemical Background And Receptor Activity — Field Notes

By Editorial Desk · published 2026-05-17 · last reviewed 2026-06-01 · Data

The short version of cyclic heptapeptide fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2026-06-01 and is reviewed periodically as new material appears.

Chemical Background and Receptor Activity

Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.

The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.

Origins and Research Status

The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.

Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.

Melanotan-2 at a glance

PropertyValueNotes
Chemical classSynthetic cyclic heptapeptideAlpha-MSH analogue with a lactam ring
Molecular formulaC50H69N15O9Commonly cited value for the neutral peptide
Molecular weight1024.18 g/molCalculated for the free molecule
AppearanceWhite to off-white powderTypically supplied as a lyophilised solid
SolubilitySoluble in water, DMSO and ethanolDissolution in pure water is often slow

Peptide Identity and Structural Background

Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.

Related pages on this site

Identity and Chemical Background

Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.

Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.

Further detail

=== Others === Syringes are used to refill ink in fountain pens and printer ink cartridges. Common workshop applications include injecting glue into tight spots to repair joints where disassembly is impractical or impossible; and injecting lubricants onto working surfaces without spilling. Sometimes a large hypodermic syringe is used without a needle for very small baby mammals to suckle from in artificial rearing. Historically, large pumps that use reciprocating motion to pump water were referred to as syringes. Pumps of this type were used as early firefighting equipment. There are fountain syringes where the liquid is in a bag or can and goes to the nozzle via a pipe. In earlier times, clyster syringes were used for that purpose. Loose snus is often applied using modified syringes. The nozzle is removed so the opening is the width of the chamber. The snus can be packed tightly into the chamber and plunged into the upper lip. Syringes, called portioners, are also manufactured for this particular purpose.

== Death and race continuation == On March 27, 2012, True failed to return after heading out for a run in the Gila Wilderness, part of the Gila National Forest in southwestern New Mexico. He departed from the Wilderness Lodge in Gila, saying he was going for a 12-mile (19 km) run. A subsequent mountain rescue effort involved three aircraft and at least nine search and rescue teams in off-road vehicles and on horseback, looking across 200,000 acres (81,000 ha) of high desert. Searchers included ultra-runners such as Scott Jurek, Kyle Skaggs, Timothy Olson, and many athletes and friends who had participated in the 51 mile Copper Canyon Ultra Marathon. On March 31, True was found dead with his legs dangling in a stream. The local sheriff said there were "no obvious signs of trauma", although True had scrapes and abrasions on his hands, arms, and knees, suggesting a fall. His remains were removed by horseback. Because of difficult terrain and remote location, the recovery was not completed until April 1. An autopsy was inconclusive with respect to the actual cause of death, revealing, however, that True was suffering from idiopathic cardiomyopathy, which had caused the left ventricle of his heart to become enlarged.

=== Stagg Damages === Stagg sued the police for damages totalling £1 million following the fourteen months he spent in custody. He has co-written and published two books about the case: Who Really Killed Rachel? (with novelist David Kessler) and, more recently, Pariah (with journalist Ted Hynds), the latter being published on the same day as the real culprit's appearance in court to enter a plea. In January 2007, the Home Office confirmed that Stagg would receive compensation for wrongful prosecution, with the amount to be set by an independent assessor. On 13 August 2008, it was announced that the compensation was £706,000. In December 2008, Colin Stagg finally received a public apology from the Metropolitan Police for their previous involvement and prosecution of him in regard to the Nickell murder investigation. He also received an apology from Robert Napper, delivered via his QC.

Copper-free click chemistry is being explored for use in synthesizing PET imaging agents which must be made quickly with high purity and yield in order to minimize isotopic decay before the compounds can be administered. Both the high rate constants and the bioorthogonality of SPAAC are amenable to PET chemistry.

Sources: en.wikipedia.org

Supporting material

== Preptin == Preptin, a 34-aa peptide hormone produced by the pancreas, kidneys, breast tissues, and salivary glands, is derived from proteolytic cleavage of IGF-2 proprotein. The sequence of preptin (amino acids 93-126 of canonical IGF-2 preproprotein) is flanked by an N-terminal arginine (Arg) cleavage site and a C-terminal putative dibasic (Arg-Arg) cleavage motif. Preptin is present in islet beta-cells, undergoes glucose-mediated co-secretion with insulin, and acts as a physiological amplifier of glucose-mediated insulin secretion. It has an anabolic impact on bone growth and exhibits osteogenic properties, increasing osteoblast mitogenic activity through phosphoactivation of MAPK1 and MAPK3. This activity resides within the first 16 amino acids of preptin. Genetic ablation of the preptin-coding region of Igf2 in female mice impairs pancreatic function.

The 5-HT2C receptors are G protein–coupled receptors that are coupled to phospholipase C (PLC) via Gαq, phospholipase A2 (PLA2), and possibly Gα13. PLC metabolizes phosphatidylinositol 4,5-bisphosphate into inositol 1,4,5-triphosphate (IP3). IP3 regulates cellular Ca2+ flux by binding to IP3 receptors, inducing Ca2+ release. In addition, the activation of PLA2 also results in recruitment of a RhoA/PLD pathway through RhoA, an enzyme that regulates a wide spectrum of cellular functions through PLD (phospholipase D) target protein. The 5-HT2C receptors can also stimulate the extracellular signal-regulated kinase (ERK) pathway which is activated by neurotrophins and other neuroactive chemicals. Production of these chemicals effects neuronal differentiation, survival, regeneration, and structural and functional plasticity. Early studies of the ERK pathway showed that mood stabilizers for the treatment of manic-depressive illness stimulated the pathway. This led to the understanding that stimulation of the 5-HT2C receptors could regulate manic-depressive conditions in a manner similar to mood stabilizers. 5-HT2C receptors are located only within the CNS, where they can be found in several locations. The highest density of receptor expression is within the choroid plexus. Other brain locations include the nucleus of the solitary tract, dorsomedial hypothalamus, paraventricular hypothalamic nucleus and the amygdala, all of which are associated with regulation of food intake.

Some of the steel transmitter towers remain, although the wooden receiver towers have all been demolished. The remaining towers have various new uses and in some cases are now protected as listed buildings by order of English Heritage. One such 360-foot-high (110 m) transmitter tower can now be found at the BAE Systems facility at Great Baddow in Essex, on the former Marconi Research Centre site. It originally stood at RAF Canewdon in Essex and was moved to Great Baddow in 1956. This is the only surviving Chain Home tower still in its original, unmodified form with cantilever platforms at 50 ft, 200 ft and 360 ft, and in 2019 was given Grade II listed status. Swingate transmitting station in Kent (originally AMES 04 Dover) has two original towers (three until 2010) which are used for microwave relay; the towers lost their platforms in the 1970s. RAF Stenigot in Lincolnshire has another, almost complete tower, without its top platforms; it is used for training aerial erectors. The only original Chain Home site which is still used as a military radar station is RRH Staxton Wold in North Yorkshire, although there are no remnants of the 1937 equipment as it was completely cleared and remodelled for the ROTOR replacement, the Linesman/Mediator system, in 1964. The 240-foot timber receiver towers were some of the tallest wooden structures ever built in Britain. Two of these wooden towers were still standing in 1955, at Hayscastle Cross. Unlike the transmitter tower pictured here, those at Hayscastle Cross were guyed.

Attempts to contact by mail in the late 1890s failed. United Brothers of Friendship - Founded August 1, 1861, by young local students in day or night schools. In 1868, on the advice of their teacher, W.H. Gibson, the society reorganized. Many chapters were formed in Kentucky, and a statewide Grand Lodge was formed in 1871. After establishing chapters outside Kentucky a National Grand Lodge was formed. W.H. Gibson served as the first State Grand Master for five years and as National Grand Master for four years. Unofficial female auxiliaries were called the Sisters of Friendship until 1878 when the organization formed the official Sisters of the Mysterious Ten, organized in local Temples. In 1878 the Order had about 4,000 members. That was the year they decided to establish another auxiliary, the Knights of Friendship, based on the story of David and Jonathan. In 1892 the UBF had 100,000 members in 19 states and 2 territories with 30,000 in Missouri alone. It was known to be active in Kentucky, Missouri, Arkansas, Louisiana, Texas, Mississippi, Alabama, Tennessee, West Virginia, Virginia, the District of Columbia, Pennsylvania, New York, New Jersey, Michigan, Kansas, Colorado, Washington, Canada, the West Indies and Africa. While predominantly black, the order had white members. There was evidence that the Grand United Order of Odd Fellows had something to do with its founding. United Knights and Daughters of America - Headquartered in St. Louis, Missouri. Reportedly had many members in the Midwest. Attempts to contact the order in 1923 were unsuccessful.

== Taxonomy == This species is named in honor of Keisuke Ito, a Japanese physician and biologist. A named cultivar of this species, "Koidzumi", refers to botanist Gen'ichi Koizumi. The Japanese name of Angelica keiskei, "ashitaba" (tomorrow-leaf), stems from the above-average regenerative capabilities it exhibits after injury.

Sources: en.wikipedia.org

Frequently asked questions

What class of compound is melanotan-2?

It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.

Is melanotan-2 an approved medicine?

No national medicines agency has approved melanotan-2 for clinical use. Afamelanotide, a related but distinct peptide, holds a marketing authorisation in the European Union for a rare photosensitivity disorder. Melanotan-2 itself is handled as a laboratory chemical.

Why does melanotan-2 attract research interest?

Its broad activity across melanocortin receptors makes it a tool for probing pigmentation, appetite and vascular signalling. Early trials recorded skin darkening and other effects that were not the original focus of the work. Those observations generated hypotheses that later studies have examined.

What is melanotan II?

It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.

Network